For decades, the message was simple: eat less cholesterol, lower your risk of heart disease.

Avoid eggs. Watch your saturated fat. Get your LDL down and your HDL up. That’s the whole story.

It wasn’t.

The science has been shifting for years — not toward “cholesterol doesn’t matter,” but toward a more precise understanding of which numbers actually predict risk.

If your doctor only checks total LDL and calls it done, there’s a good chance you’re being measured with a tool the medical establishment is actively moving away from.

Array

Disclosure: Hometalk may receive a small affiliate commission from purchases made via links in this article but at no cost to you.

The Dietary Cholesterol Rule That Got Quietly Scrapped

Here’s the one that surprises most people: the 300mg daily limit on dietary cholesterol — the rule that demonized eggs and shellfish for a generation — was removed from US dietary guidelines in 2015.

Not reduced. Removed entirely.

The 2015 Dietary Guidelines for Americans dropped the cholesterol limit and included eggs in all three recommended healthy eating patterns, partly because dietary cholesterol has minimal impact on blood cholesterol for most people.

The body compensates — when you eat more cholesterol, the liver generally produces less.

A 2013 meta-analysis of 16 studies involving nearly 350,000 participants found no significant relationship between egg intake and cardiovascular disease or stroke.

The 300mg rule had been in place since 1968 — and more than one generation of Americans made dietary decisions based on guidance the evidence didn’t fully support.

“Good” Cholesterol Isn’t Always Good

The second revision to the standard story is less widely known. For decades, the framing was binary: LDL bad, HDL good. Raise your HDL and you’re protected. It turns out not to be that simple.

Research presented at the European Society of Cardiology Congres s found that very high HDL levels may be associated with increased risk of heart attack and death, leading researchers to conclude that “the mantra of HDL as the ‘good’ cholesterol may no longer be the case for everyone”.

A separate NIH-funded study published in 2022 found that higher HDL levels were not protective against heart attack risk in either Black or white adults.

Low HDL is still a meaningful risk signal. What the science has moved away from is the assumption that raising HDL is automatically protective.

Clinical trials that pharmacologically raised HDL levels consistently failed to reduce cardiovascular events. The relationship is more complex than the standard panel implies.

The Number Your Doctor Probably Isn’t Checking

This is where the science has moved most decisively. LDL cholesterol — the number most people recognize from their annual panel — measures the cholesterol content inside LDL particles.

What it doesn’t tell you is particle count.

Two people with identical LDL numbers can have dramatically different cardiovascular risk depending on particle count and density.

The marker that better captures this is apolipoprotein B, or ApoB.

Each atherogenic particle in the blood carries exactly one ApoB molecule, meaning ApoB counts the particles that can deposit in artery walls — regardless of how much cholesterol each one carries.

The European Society of Cardiology recommended ApoB over LDL-C as a risk marker as far back as 2019.

In March 2026, the US caught up: the new AHA/ACC Dyslipidemia Guideline formally recommends ApoB testing for adults on lipid-lowering therapy, particularly those with diabetes, elevated triglycerides, or established cardiovascular disease.

The guideline notes that in about 20% of people, LDL-C can appear normal while ApoB is elevated — meaning actual risk is higher than the standard test shows.

Despite this, less than 1% of insured Americans currently get their ApoB tested each year.

Array

None of this means cholesterol doesn’t matter. LDL remains a meaningful target and statins have a robust evidence base.

What the science is clarifying is that the standard lipid panel tells an incomplete story for a significant portion of the population.

If you have diabetes, metabolic syndrome, or elevated triglycerides, your LDL number may underestimate your actual risk.

If your LDL looks normal but your ApoB is elevated, you may be among the 20% of people whose standard results are misleading.

The conversation worth having with your doctor isn’t just “what’s my LDL?” It’s “do I need an ApoB test?” — and the updated guidelines say yes.